Literature DB >> 18095329

Intersection of nuclear receptors and the proteasome on the epigenetic landscape.

H Karimi Kinyamu1, Wendy N Jefferson, Trevor K Archer.   

Abstract

Nuclear receptors (NRs) represent a class of transcription factors that associate with both positive and negative chromatin modifying complexes to activate or repress gene transcription. The 26S proteasome plays a major role in NR-regulated gene transcription by tightly regulating the levels of the receptor and coregulator complexes. Recent evidence suggests a robust nonproteolytic role for specific proteasome subunits in gene transcription mediated via alterations in specific histone modifications. The involvement of nuclear receptors and the proteasome with chromatin modifying complexes or proteins, particularly those that modify DNA and histone proteins, provides an opportunity to review two critical epigenetic mechanisms that control gene expression and heritable biological processes. Both nuclear receptors and the proteasome are targets of environmental factors including some which lead to epigenetic changes that can influence human diseases such as cancer. In this review, we will explore molecular mechanisms by which NR-mediated gene expression, under the control of the proteasome, can result in altered epigenetic landscapes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18095329      PMCID: PMC2482603          DOI: 10.1002/em.20360

Source DB:  PubMed          Journal:  Environ Mol Mutagen        ISSN: 0893-6692            Impact factor:   3.216


  125 in total

Review 1.  Methylation-induced repression--belts, braces, and chromatin.

Authors:  A P Bird; A P Wolffe
Journal:  Cell       Date:  1999-11-24       Impact factor: 41.582

Review 2.  The 26S proteasome: a molecular machine designed for controlled proteolysis.

Authors:  D Voges; P Zwickl; W Baumeister
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

Review 3.  Receptor null mice reveal contrasting roles for estrogen receptor alpha and beta in reproductive tissues.

Authors:  J F Couse; S Curtis Hewitt; K S Korach
Journal:  J Steroid Biochem Mol Biol       Date:  2000-11-30       Impact factor: 4.292

Review 4.  Genomic DNA methylation: the mark and its mediators.

Authors:  Robert J Klose; Adrian P Bird
Journal:  Trends Biochem Sci       Date:  2006-01-05       Impact factor: 13.807

Review 5.  Mechanisms of epigenetic inheritance.

Authors:  Cyrus Martin; Yi Zhang
Journal:  Curr Opin Cell Biol       Date:  2007-04-26       Impact factor: 8.382

6.  Proliferative lesions and reproductive tract tumors in male descendants of mice exposed developmentally to diethylstilbestrol.

Authors:  R R Newbold; R B Hanson; W N Jefferson; B C Bullock; J Haseman; J A McLachlan
Journal:  Carcinogenesis       Date:  2000-07       Impact factor: 4.944

7.  Proteasome activity modulates chromatin modifications and RNA polymerase II phosphorylation to enhance glucocorticoid receptor-mediated transcription.

Authors:  H Karimi Kinyamu; Trevor K Archer
Journal:  Mol Cell Biol       Date:  2007-04-16       Impact factor: 4.272

8.  The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation.

Authors:  D M Lonard; Z Nawaz; C L Smith; B W O'Malley
Journal:  Mol Cell       Date:  2000-06       Impact factor: 17.970

9.  Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D.

Authors:  Sook Shin; Ralf Janknecht
Journal:  Biochem Biophys Res Commun       Date:  2007-06-04       Impact factor: 3.575

10.  Diverse histone modifications on histone 3 lysine 9 and their relation to DNA methylation in specifying gene silencing.

Authors:  Jiejun Wu; Shu-Huei Wang; Dustin Potter; Joseph C Liu; Laura T Smith; Yue-Zhong Wu; Tim H-M Huang; Christoph Plass
Journal:  BMC Genomics       Date:  2007-05-24       Impact factor: 3.969

View more
  8 in total

Review 1.  Emerging roles of the 26S proteasome in nuclear hormone receptor-regulated transcription.

Authors:  Brian R Keppler; Trevor K Archer; H Karimi Kinyamu
Journal:  Biochim Biophys Acta       Date:  2010-08-20

Review 2.  Epigenomics, gestational programming and risk of metabolic syndrome.

Authors:  M Desai; J K Jellyman; M G Ross
Journal:  Int J Obes (Lond)       Date:  2015-02-02       Impact factor: 5.095

3.  Differential glucocorticoid receptor-mediated transcription mechanisms.

Authors:  Sayura Aoyagi; Trevor K Archer
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

4.  Reactivation of L1 retrotransposon by benzo(a)pyrene involves complex genetic and epigenetic regulation.

Authors:  Ivo Teneng; Diego E Montoya-Durango; James L Quertermous; Mary E Lacy; Kenneth S Ramos
Journal:  Epigenetics       Date:  2011-03-01       Impact factor: 4.528

5.  Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells: a novel therapeutic modality.

Authors:  Alexander Yemelyanov; Pankaj Bhalla; Ximing Yang; Andrey Ugolkov; Kenichi Iwadate; Apollon Karseladze; Irina Budunova
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

6.  Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies.

Authors:  Ekaterina Lesovaya; Alexander Yemelyanov; Kirill Kirsanov; Alexander Popa; Gennady Belitsky; Marianna Yakubovskaya; Leo I Gordon; Steven T Rosen; Irina Budunova
Journal:  Cell Cycle       Date:  2012-12-19       Impact factor: 4.534

7.  Proteasome subunits relocalize during human cytomegalovirus infection, and proteasome activity is necessary for efficient viral gene transcription.

Authors:  Karen Tran; Jeffrey A Mahr; Deborah H Spector
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

8.  Combination Treatment with Sublethal Ionizing Radiation and the Proteasome Inhibitor, Bortezomib, Enhances Death-Receptor Mediated Apoptosis and Anti-Tumor Immune Attack.

Authors:  Ercan Cacan; Alexander M Spring; Anita Kumari; Susanna F Greer; Charlie Garnett-Benson
Journal:  Int J Mol Sci       Date:  2015-12-21       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.